Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-11 Sale |
2021-11-12 4:54 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
11,160 | $163.02 | $1,819,255 | 190,873 (Direct) |
View |
2021-08-04 Sale |
2021-08-05 4:44 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
8,840 | $109.67 | $969,507 | 202,595 (Direct) |
View |
2021-02-10 Sale |
2021-02-12 6:23 pm |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
5,083 | $213.14 | $1,083,410 | 50,152 (Direct) |
View |
2021-02-09 Sale |
2021-02-11 4:06 pm |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
14,670 | $208.53 | $3,059,123 | 24,431 (Direct) |
View |
2021-02-05 Sale |
2021-02-09 6:08 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
54,666 | $203.4 | $11,119,239 | 357,394 (Direct) |
View |
2021-02-04 Sale |
2021-02-05 5:03 pm |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
18,097 | $178.5 | $3,230,376 | 35,861 (Direct) |
View |
2021-02-04 Sale |
2021-02-05 5:03 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
44,547 | $176.86 | $7,878,582 | 264,544 (Direct) |
View |
2021-01-25 Sale |
2021-01-27 7:04 pm |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
90,000 | $169.22 | $15,230,000 | 517,038 (Direct) |
View |
2020-11-02 Purchase |
2020-11-04 4:19 pm |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
1,000 | $82.52 | $82,520 | 28,190 (Direct) |
View |
2020-08-26 Sale(A) |
2020-08-28 5:11 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) |
View |
2020-08-25 Sale |
2020-08-27 7:06 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-11-11 Exercise |
2021-11-12 4:54 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
12,188 | $0 | 190,873 (Direct) |
View |
2021-11-11 Exercise |
2021-11-12 4:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
11,160 | $21.92 | 190,873 (Direct) |
View |
2021-11-11 Exercise |
2021-11-12 4:54 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
1,028 | $100.38 | 190,873 (Direct) |
View |
2021-08-04 Exercise |
2021-08-05 4:44 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
9,982 | $0 | 202,595 (Direct) |
View |
2021-08-04 Exercise |
2021-08-05 4:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
8,840 | $21.92 | 202,595 (Direct) |
View |
2021-08-04 Exercise |
2021-08-05 4:44 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
1,142 | $85.79 | 202,595 (Direct) |
View |
2021-07-12 Option Award |
2021-07-14 8:19 pm |
2022-07-12 2031-07-12 |
LIGAND PHARMACEUTICALS INC | LGND | Cochran Jennifer R. Director |
5,669 | $0 | 5,669 (Direct) |
View |
2021-06-30 Other |
2021-07-02 5:14 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
247 | $85.91 | 338,342 (Direct) |
View |
2021-06-30 Other |
2021-07-02 5:13 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
247 | $85.91 | 39,937 (Direct) |
View |
2021-06-04 Option Award |
2021-06-08 2:26 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
3,899 | $0 | 30,798 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:39 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director |
3,899 | $0 | 128,552 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:25 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director |
3,899 | $0 | 6,161 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:25 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
3,899 | $0 | 54,051 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:24 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director |
3,899 | $0 | 6,971 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:24 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
3,899 | $0 | 38,051 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:24 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director |
3,899 | $0 | 28,667 (Direct) |
View |
2021-06-04 Option Award |
2021-06-07 9:23 pm |
N/A 2031-06-04 |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
3,899 | $0 | 32,089 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 4:59 pm |
N/A 2025-02-10 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
1,755 | $0 | 204,713 (Direct) |
View |
2021-05-28 Gift |
2021-06-01 4:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
2,500 | $0 | 204,713 (Direct) |
View |
2021-05-28 Exercise |
2021-06-01 4:59 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
1,755 | $56.26 | 204,713 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:57 pm |
N/A 2012-06-01 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
4,835 | $0 | 34,152 (Direct) |
View |
2021-05-11 Tax Withholding |
2021-05-13 8:57 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
391 | $128.56 | 34,152 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:57 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
4,835 | $10.12 | 34,152 (Direct) |
View |
2021-02-22 Exercise |
2021-02-23 5:18 pm |
N/A 2012-06-01 |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,500 | $0 | 34,543 (Direct) |
View |
2021-02-22 Exercise |
2021-02-23 5:18 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director |
2,500 | $10.12 | 34,543 (Direct) |
View |
2021-02-15 Tax Withholding |
2021-02-18 6:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
1,015 | $172.46 | 27,891 (Direct) |
View |
2021-02-15 Tax Withholding |
2021-02-18 6:28 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
3,098 | $172.46 | 165,100 (Direct) |
View |
2021-02-15 Tax Withholding |
2021-02-18 6:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
5,212 | $172.46 | 337,848 (Direct) |
View |
2021-02-15 Tax Withholding |
2021-02-18 6:27 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
2,309 | $172.46 | 39,443 (Direct) |
View |
2021-02-11 Exercise |
2021-02-12 6:23 pm |
N/A 2028-06-18 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,474 | $0 | 50,152 (Direct) |
View |
2021-02-11 Exercise |
2021-02-12 6:23 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,474 | $195.91 | 50,152 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:06 pm |
N/A 2021-06-01 |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
14,670 | $0 | 24,431 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:06 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
7,335 | $12.53 | 24,431 (Direct) |
View |
2021-02-09 Exercise |
2021-02-11 4:06 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director |
7,335 | $10.12 | 24,431 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 6:08 pm |
N/A 2021-02-17 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
114,666 | $0 | 357,394 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 6:08 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
54,666 | $14.47 | 357,394 (Direct) |
View |
2021-02-05 Tax Withholding |
2021-02-09 6:08 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
2,970 | $203.03 | 357,394 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 6:08 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
60,000 | $10.05 | 357,394 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 5:03 pm |
N/A 2021-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
10,446 | $0 | 35,861 (Direct) |
View |
2021-02-04 Exercise |
2021-02-05 5:03 pm |
N/A 2023-02-15 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
45,547 | $0 | 264,544 (Direct) |
View |
2021-02-04 Exercise |
2021-02-05 5:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
1,000 | $74.42 | 264,544 (Direct) |
View |
2021-02-04 Exercise |
2021-02-05 5:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
44,547 | $21.92 | 264,544 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 5:03 pm |
N/A 2031-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
19,731 | $0 | 264,544 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 5:02 pm |
N/A 2031-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
37,721 | $0 | 311,143 (Direct) |
View |
2021-02-03 Option Award |
2021-02-05 5:02 pm |
N/A 2031-02-03 |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
22,410 | $0 | 53,343 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 7:04 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
120,000 | $0 | 517,038 (Direct) |
View |
2021-01-27 Exercise |
2021-01-27 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
30,000 | $21.92 | 517,038 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
90,000 | $14.47 | 517,038 (Direct) |
View |
2021-01-25 Option Award |
2021-01-27 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
15,553 | $0 | 517,038 (Direct) |
View |
2021-01-25 Tax Withholding |
2021-01-27 7:04 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
7,441 | $156.01 | 517,038 (Direct) |
View |
2021-01-25 Option Award |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
8,515 | $0 | 160,603 (Direct) |
View |
2021-01-25 Tax Withholding |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
3,325 | $156.01 | 160,603 (Direct) |
View |
2021-01-25 Option Award |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
7,108 | $0 | 30,933 (Direct) |
View |
2021-01-25 Tax Withholding |
2021-01-27 7:03 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E EVP,Finance & Strategy and CFO |
2,111 | $156.01 | 30,933 (Direct) |
View |
2021-01-25 Tax Withholding |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
509 | $156.1 | 43,512 (Direct) |
View |
2021-01-25 Option Award |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
3,736 | $0 | 43,512 (Direct) |
View |
2021-01-25 Tax Withholding |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S SVP, Gen. Counsel & Secretary |
830 | $156.01 | 43,512 (Direct) |
View |
2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A 2027-05-25 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $0 | 52,761 (Direct) |
View |
2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $113.5 | 52,761 (Direct) |
View |
2020-12-31 Other |
2021-01-05 8:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
223 | $84.53 | 235,533 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 6:12 pm |
N/A 2021-02-17 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
14,657 | $0 | 295,087 (Direct) |
View |
2020-12-08 Exercise |
2020-12-09 6:12 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
14,657 | $10.05 | 295,087 (Direct) |
View |
2020-12-08 Tax Withholding |
2020-12-09 6:12 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,683 | $87.52 | 295,087 (Direct) |
View |
2020-11-09 Exercise |
2020-11-10 7:41 pm |
N/A 2021-02-17 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,000 | $0 | 296,770 (Direct) |
View |
2020-11-09 Exercise |
2020-11-10 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,000 | $10.05 | 296,770 (Direct) |
View |
2020-11-09 Tax Withholding |
2020-11-10 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
2,458 | $81.77 | 296,770 (Direct) |
View |
Ownership |
2020-10-09 06:30 am |
N/A N/A |
Pfenex Inc. | PFNX | LIGAND PHARMACEUTICALS INC 10% Owner |
0 | $0 | 27,034,437 (Direct) |
View |